News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,847 Results
Type
Article (40227)
Company Profile (289)
Press Release (653331)
Section
Business (206400)
Career Advice (2001)
Deals (35766)
Drug Delivery (85)
Drug Development (81029)
Employer Resources (168)
FDA (16282)
Job Trends (14927)
News (348108)
Policy (32752)
Tag
Academia (2573)
Alliances (49963)
Alzheimer's disease (1244)
Approvals (16208)
Artificial intelligence (129)
Bankruptcy (356)
Best Places to Work (11595)
Biotechnology (201)
Breast cancer (116)
Cancer (1035)
Cardiovascular disease (86)
Career advice (1671)
Cell therapy (220)
Clinical research (64277)
Collaboration (367)
Compensation (188)
COVID-19 (2553)
C-suite (90)
Data (1043)
Diabetes (150)
Diagnostics (6514)
Earnings (85572)
Employer resources (146)
Events (110582)
Executive appointments (281)
FDA (16790)
Funding (332)
Gene therapy (171)
GLP-1 (573)
Government (4366)
Healthcare (18857)
Infectious disease (2635)
Inflammatory bowel disease (105)
Interviews (311)
IPO (16439)
Job creations (3684)
Job search strategy (1429)
Layoffs (415)
Legal (7903)
Lung cancer (166)
Manufacturing (171)
Medical device (13314)
Medtech (13319)
Mergers & acquisitions (19383)
Metabolic disorders (391)
Neuroscience (1503)
NextGen Class of 2024 (6544)
Non-profit (4519)
Northern California (1415)
Obesity (227)
Opinion (179)
Patents (98)
People (56867)
Phase I (19954)
Phase II (28321)
Phase III (21105)
Pipeline (441)
Postmarket research (2557)
Preclinical (8503)
Radiopharmaceuticals (241)
Rare diseases (207)
Real estate (5982)
Regulatory (21730)
Research institute (2349)
Resumes & cover letters (351)
Southern California (1273)
Startups (3641)
United States (13122)
Vaccines (548)
Weight loss (165)
Date
Last 7 days (924)
Last 30 days (3442)
Last 365 days (35699)
2024 (32363)
2023 (40430)
2022 (51549)
2021 (56107)
2020 (54586)
2019 (46975)
2018 (35405)
2017 (32524)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (729)
Arizona (192)
Asia (37854)
Australia (6199)
California (3200)
Canada (1256)
China (238)
Colorado (143)
Connecticut (143)
Europe (81736)
Florida (439)
Georgia (118)
Illinois (341)
Indiana (192)
Kansas (97)
Maryland (570)
Massachusetts (2530)
Michigan (153)
Minnesota (276)
New Jersey (926)
New York (931)
North Carolina (724)
Northern California (1415)
Ohio (134)
Pennsylvania (815)
South America (1109)
Southern California (1273)
Texas (439)
Utah (89)
Washington State (357)
693,847 Results for "ariosa diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Press Releases
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
November 7, 2024
·
10 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Press Releases
Breath Diagnostics Inc. Appoints Aaron Roebuck as President and Closes Financing
November 1, 2024
·
4 min read
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
November 13, 2024
·
4 min read
Business
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
October 25, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
Press Releases
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
November 6, 2024
·
1 min read
Press Releases
Bracco Diagnostics Inc. Obtains Hallmark Achievement of One Million Injections with its MRI agent VUEWAY® (gadopiclenol) solution for injection
November 12, 2024
·
7 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
1 of 69,385
Next
